Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...
Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback